In human tongue squamous cell carcinoma lines CAL-27 and HSC-3, IL-6 treatment resulted in enhanced nucleotide synthesis and increased G6PD activity, thereby activating the PPP, although G6PD protein expression remained unchanged [28]. The gene discussed is G6PD; the disease is tongue squamous cell carcinoma.